Hyperinsulinemia Does Not Change Atherosclerosis Development in Apolipoprotein E Null Mice
Christian Rask‐Madsen(University of Ulsan), George L. King(Joslin Diabetes Center), Oluwatobi Yerokun(Louisville Metabolic and Atherosclerosis Research Center), Mark D. Rekhter(Memorial Hermann), Allen C. Clermont(Joslin Diabetes Center), Kyoungmin Park(Joslin Diabetes Center), Qian Li(University of North Carolina at Chapel Hill), Erica L. Buonomo(Louisville Metabolic and Atherosclerosis Research Center)
Cited by 33
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k